Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Cancer Lett ; 201(2): 139-48, 2003 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-14607327

RESUMO

Cancer cachexia is characterized by anorexia and intense peripheral catabolism. We examine the potential benefits of combination of different anabolic agents such as insulin and clenbuterol associated to prostaglandin synthesis inhibitor (naproxen) on tumor growth, cachexia and renal function in Walker 256 tumor-bearing rats (WK). Groups were separated into WK, and WK with naproxen (WK N) or naproxen plus clenbuterol (WK NCb) or naproxen plus clenbuterol plus insulin (WK NCbI). Treatment begins at the 4th day after tumor inoculation, at the 14th day they were killed, glycemia, lacticidemia, glycogen content from liver, soleus and gastrocnemius muscles, tumor mass, body weight and kidney function were determined. Glycemia and glycogen content were reduced and lacticidemia increased in WK (p<0.05) as compared to control rats. The glycogen content recovered in all treated groups. Tumor weight was significantly reduced by the different treatments. At the 14th weight change (carcass-initial body weight) in the control increased by 38% and in the WK -2%. Naproxen treatment (WK N) induced an increased by 14%. The inclusion of clenbuterol (WK NCb) and insulin (WK NCbI) by 38 and 41%, respectively. Mean glomerular filtration rate (GFR) increased in the WK (p<0.05) as compared to control, but in the WK NCb the GFR was similar to control. Our results suggest that naproxen is able to reduce tumor growth and its association with insulin and clenbuterol induce mass weight gain and recovery energy fuel.


Assuntos
Caquexia/tratamento farmacológico , Carcinoma 256 de Walker/tratamento farmacológico , Clembuterol/uso terapêutico , Insulina/uso terapêutico , Naproxeno/uso terapêutico , Agonistas Adrenérgicos beta/uso terapêutico , Animais , Glicemia/análise , Peso Corporal/efeitos dos fármacos , Carcinoma 256 de Walker/patologia , Inibidores de Ciclo-Oxigenase/uso terapêutico , Quimioterapia Combinada , Ingestão de Alimentos/efeitos dos fármacos , Ingestão de Energia , Glicogênio/metabolismo , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Ratos , Ratos Wistar
2.
Br Homeopath J ; 89 Suppl 1: S14-9, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10939776

RESUMO

UNLABELLED: Problems which the development attempts to address. This study's overall objectives were to determine whether: * The aims of collaboration between General Practitioner (GPs) and a homeopath can be made explicit and service delivery optimised by using computer-based data collection in a multi-disciplinary primary care team that includes a homeopathic practitioner. * Outcomes of the homeopathic service can be evaluated in a practical way, which allows quality assurance through rapid audit cycles. METHOD: The primary care team (PCT) explored the problems of developing a rational and quality assured complementary therapy service in a series of meetings in an NHS practice where complementary therapists are members of the PCT. This led to the defining of data-collection structures and processes needed. The researchers designed and supervised their implementation and evaluation through a series of action research cycles. A database was designed which allowed the clinicians to track interventions and outcomes using the Measure Your Own Medical Outcome Profile (MYMOP). Critical incidents were brought to fortnightly clinical meetings and methods were continually adapted as problems arose and new options emerged at six-weekly audit meetings. RESULTS: GPs tended to refer patients who do not fit easily into biomedical disease categories. Patients referred tend to self-rate themselves as experiencing notably poor wellbeing. MYMOP has to be used skillfully with homeopathic patients, especially where psychological distress is identified as one of their main complaints. CONCLUSIONS: It is possible to introduce rigour and reflectiveness when providing a homeopathic service in general practice by assessing the needs of patient and practitioners, agreeing intake guidelines, developing referral processes, implementing audit cycles. Clear lines of communication can be established and a patient-centred outcome measure can be introduced into the treatment cycle.


Assuntos
Sistemas de Gerenciamento de Base de Dados , Medicina de Família e Comunidade/organização & administração , Homeopatia/organização & administração , Avaliação de Resultados em Cuidados de Saúde , Administração da Prática Médica/normas , Garantia da Qualidade dos Cuidados de Saúde/métodos , Medicina de Família e Comunidade/normas , Homeopatia/normas , Humanos , Londres
3.
Br. homoeopath. j ; 89(supl.1): S14-S19, july 2000. tab
Artigo em Inglês | HomeoIndex (homeopatia) | ID: hom-5980

RESUMO

Problems which the development attempts to address. This study's overall objectives were to determine whether: the aims of collaboration between General Practitioner (GPs) and a homeopath... (AU)


Assuntos
Atenção Primária à Saúde , Equipe de Assistência ao Paciente , Inglaterra
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa